We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Catalent Invests $4.6M To Further Expand Asia–Pacific Clinical Trials

News   Feb 05, 2016

 
Catalent Invests $4.6M To Further Expand Asia–Pacific Clinical Trials
 
 
 

RELATED ARTICLES

Proactive Approach Protects Population From HIV

News

A preventative approach to HIV drastically reduced the number of HIV diagnoses in New South Wales, Australia.

READ MORE

Attacking RNA with Small-molecule Drugs

News

Yale researchers have developed a way to target RNA with small-molecule drugs, creating a new method for tapping into a vast number of biological mechanisms critical to metabolism and gene expression.

READ MORE

Paralysis from Rare Disorder: Stem Cell Therapy Trial Brings Hope

News

A clinical trial is planned to see if a single injection of progenitor cells can help repair spinal cords inflamed by transverse myelitis.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE